Cleared Traditional

FERR FLEX REAGENT CARTRIDGE (K963498) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K963498 · Dade Chemistry Systems, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1997
Decision
143d
Days
Class 2
Risk

K963498 is an FDA 510(k) clearance for the FERR FLEX REAGENT CARTRIDGE. Classified as Radioimmunoassay (two-site Solid Phase), Ferritin (product code JMG), Class II - Special Controls.

Submitted by Dade Chemistry Systems, Inc. (Newark, US). The FDA issued a Cleared decision on January 24, 1997 after a review of 143 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 866.5340 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Dade Chemistry Systems, Inc. devices

Submission Details

510(k) Number K963498 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 03, 1996
Decision Date January 24, 1997
Days to Decision 143 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
55d slower than avg
Panel avg: 88d · This submission: 143d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JMG Radioimmunoassay (two-site Solid Phase), Ferritin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JMG Radioimmunoassay (two-site Solid Phase), Ferritin

All 23
Devices cleared under the same product code (JMG) and FDA review panel - the closest regulatory comparables to K963498.
Access Ferritin
K234052 · Beckman Coulter, Inc. · Mar 2024
FERRITIN ON THE ACCESS IMMUNOASSAY SYSTEMS, MODEL 33020
K052082 · Beckman Coulter, Inc. · Aug 2005
TINA-QUANT FERRITIN ASSAY
K964282 · Boehringer Mannheim Corp. · Jul 1997
ELECSYS FERRITIN
K971833 · Boehringer Mannheim Corp. · Jun 1997
IMMULITE FERRITIN
K925848 · Diagnostic Products Corp. · Jan 1993
COBAS CORE FERRITIN EIA
K920829 · Roche Diagnostic Systems, Inc. · Jun 1992